...
首页> 外文期刊>Thorax: The Journal of the British Thoracic Society >Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8.
【24h】

Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8.

机译:慢性阻塞性肺疾病的痰趋化活性:α(1)-抗胰蛋白酶缺乏的影响以及白三烯B(4)和白介素8的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Neutrophil recruitment to the airway is thought to be an important component of continuing inflammation and progression of chronic obstructive pulmonary disease (COPD), particularly in the presence of severe alpha(1)-antitrypsin (alpha(1)-AT) deficiency. However, the chemoattractant nature of secretions from these patients has yet to be clarified. METHODS: The chemotactic activity of spontaneous sputum from patients with stable COPD, with (n=11) and without (n=11) alpha(1)-AT deficiency (PiZ), was assessed using the under-agarose assay. The contribution of leukotriene B(4) (LTB(4)) and interleukin 8 (IL-8) to the chemotactic activity was examined using an LTB(4) receptor antagonist (BIIL 315 ZW) and an IL-8 monoclonal antibody, respectively. RESULTS: Sputum neutrophil chemotactic activity (expressed as % n-formylmethionyl leucylphenylalanine (fMLP) control) was significantly higher in patients with alpha(1)-AT deficiency (mean (SE) 63.4 (8.9)% v 36.7 (5.5)%; mean difference 26.7% (95% CI 4.9 to 48.4), p<0.05). The mean (SE) contribution of both LTB(4) and IL-8 (expressed as % fMLP control) was also significantly higher in alpha(1)-AT deficient patients than in patients with COPD with normal levels of alpha(1)-AT (LTB(4): 31.9 (6.3)% v 18.0 (3.7)%; mean difference 13.9% (95% CI -1.4 to 29.1), p<0.05; IL-8: 24.1 (5.2)% v 8.1 (1.2)%; mean difference 15.9% (95% CI 4.7 to 27.2), p<0.05). When all the subjects were considered together the mean (SE) contribution of LTB(4) (expressed as % total chemotactic activity) was significantly higher than IL-8 (46.8 (3.5)% v 30.8 (4.6)%; mean difference 16.0% (95% CI 2.9 to 29.2), p<0.05). This difference was not significantly influenced by alpha(1)-AT phenotype (p=0.606). CONCLUSIONS: These results suggest that the bronchial secretions of COPD patients with alpha(1)-AT deficiency have increased neutrophil chemotactic activity. This relates to the increased levels of IL-8 and, in particular LTB(4), which accounted most of the sputum chemotactic activity in the patients with COPD as a whole. Increased chemotactic activity, together with inhibitor deficiency, may contribute to the more rapid disease progression seen in alpha(1)-AT deficiency via increased neutrophil recruitment and release of neutrophil elastase.
机译:背景:嗜中性白细胞募集到气道被认为是持续炎症和慢性阻塞性肺疾病(COPD)进展的重要组成部分,特别是在存在严重的α(1)-抗胰蛋白酶(alpha(1)-AT)缺乏症的情况下。但是,这些患者分泌物的化学吸引性质尚未阐明。方法:使用琼脂糖下测定法评估患有(n = 11)和没有(n = 11)alpha(1)-AT缺乏症(PiZ)的稳定COPD患者的自发痰的趋化活性。分别使用LTB(4)受体拮抗剂(BIIL 315 ZW)和IL-8单克隆抗体检查白三烯B(4)(LTB(4))和白介素8(IL-8)对趋化活性的贡献。结果:α(1)-AT缺乏症患者的痰中嗜中性粒细胞趋化活性(以%n-甲酰基甲硫酰基亮氨酰苯丙氨酸(fMLP)对照表示)显着更高(平均值(SE)为63.4(8.9)%vs 36.7(5.5)%;平均值差异26.7%(95%CI 4.9至48.4),p <0.05)。在缺乏α(1)-AT的患者中,LTB(4)和IL-8的平均(SE)贡献也显着高于具有正常α(1)-水平的COPD患者AT(LTB(4):31.9(6.3)%v 18.0(3.7)%;平均差异13.9%(95%CI -1.4至29.1),p <0.05; IL-8:24.1(5.2)%v 8.1(1.2) )%;平均差异15.9%(95%CI 4.7至27.2),p <0.05)。同时考虑所有受试者时,LTB(4)的平均(SE)贡献(表示为总趋化活性的百分比)显着高于IL-8(46.8(3.5)%对30.8(4.6)%;平均差异16.0% (95%CI 2.9至29.2),p <0.05)。此差异不受alpha(1)-AT表型的显着影响(p = 0.606)。结论:这些结果表明患有α(1)-AT缺乏的COPD患者的支气管分泌物增加了中性粒细胞的趋化活性。这与IL-8尤其是LTB(4)的水平升高有关,IL-8的水平总体上占了COPD患者的大多数痰趋化活性。趋化活性的增加,以及抑制剂的缺乏,可能通过增加嗜中性粒细胞募集和释放嗜中性粒细胞弹性蛋白酶而导致更快的疾病进展,如α(1)-AT缺乏症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号